An IBD Biologic Does Not Increase Woman’s Risk of Birth Problem, Study Finds

An IBD Biologic Does Not Increase Woman’s Risk of Birth Problem, Study Finds
Women who take biologics for autoimmune disorders either three months before or during their pregnancy are not at higher risk of a preterm birth or having a smaller than normal child, a Canadian study reports. It applied to a range of autoimmune disorders, including inflammatory bowel disease (IBD). Researchers published their study in the journal Annals of the Rheumatic Diseases. The title is “Risk of preterm delivery and small-for-gestational age births in women with autoimmune disease using biologics before or during pregnancy: a populationbased cohort study.” Autoimmune disorders are characterized by dys
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *